Literature DB >> 35142994

Tetrahydrobiopterin and Its Multiple Roles in Neuropsychological Disorders.

S Swathi Krishna1, Samson K Wilson2.   

Abstract

Tetrahydrobiopterin (BH4) is a multifunctional co-factor of various enzymes and a substantial amount of studies have shown BH4 as a key regulator in the synthesis of neurotransmitters such as serotonin, nor-epinephrine as well as dopamine. The imbalance of BH4 may affect neurotransmitter production which can lead to many abnormalities in CNS. This article reviews the role of BH4 in neurodegenerative and neurodevelopmental disorders. We focus on the therapeutic potential of BH4 in various brain diseases that involves neurotransmitters and attempt to address how the modulation of BH4 may provide a novel strategy in various neuropsychological conditions.
© 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Co-factors; Dopamine; Neuro-psychological disorders; Serotonin; Tetrahydrobipterin

Mesh:

Substances:

Year:  2022        PMID: 35142994     DOI: 10.1007/s11064-022-03543-x

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  63 in total

Review 1.  Alzheimer's disease pathogenesis and therapeutic interventions.

Authors:  M S Parihar; Taruna Hemnani
Journal:  J Clin Neurosci       Date:  2004-06       Impact factor: 1.961

Review 2.  Tetrahydrobiopterin availability in Parkinson's and Alzheimer's disease; potential pathogenic mechanisms.

Authors:  Richard H Foxton; John M Land; Simon J R Heales
Journal:  Neurochem Res       Date:  2006-12-27       Impact factor: 3.996

3.  Localizing parkinsonism based on focal brain lesions.

Authors:  Juho Joutsa; Andreas Horn; Joey Hsu; Michael D Fox
Journal:  Brain       Date:  2018-08-01       Impact factor: 13.501

Review 4.  The role of 6R-tetrahydrobiopterin in the nervous system.

Authors:  K Koshimura; Y Murakami; J Tanaka; Y Kato
Journal:  Prog Neurobiol       Date:  2000-07       Impact factor: 11.685

Review 5.  The neurobiology of tetrahydrobiopterin biosynthesis: a model for regulation of GTP cyclohydrolase I gene transcription within nigrostriatal dopamine neurons.

Authors:  Gregory Kapatos
Journal:  IUBMB Life       Date:  2013-03-04       Impact factor: 3.885

Review 6.  Tau-targeting therapies for Alzheimer disease.

Authors:  Erin E Congdon; Einar M Sigurdsson
Journal:  Nat Rev Neurol       Date:  2018-07       Impact factor: 42.937

Review 7.  Neuropathology of Alzheimer's disease.

Authors:  Daniel P Perl
Journal:  Mt Sinai J Med       Date:  2010 Jan-Feb

8.  Central tetrahydrobiopterin concentration in neurodevelopmental disorders.

Authors:  Richard E Frye
Journal:  Front Neurosci       Date:  2010-07-08       Impact factor: 4.677

Review 9.  Consensus guideline for the diagnosis and treatment of tetrahydrobiopterin (BH4) deficiencies.

Authors:  Thomas Opladen; Eduardo López-Laso; Elisenda Cortès-Saladelafont; Toni S Pearson; H Serap Sivri; Yilmaz Yildiz; Birgit Assmann; Manju A Kurian; Vincenzo Leuzzi; Simon Heales; Simon Pope; Francesco Porta; Angeles García-Cazorla; Tomáš Honzík; Roser Pons; Luc Regal; Helly Goez; Rafael Artuch; Georg F Hoffmann; Gabriella Horvath; Beat Thöny; Sabine Scholl-Bürgi; Alberto Burlina; Marcel M Verbeek; Mario Mastrangelo; Jennifer Friedman; Tessa Wassenberg; Kathrin Jeltsch; Jan Kulhánek; Oya Kuseyri Hübschmann
Journal:  Orphanet J Rare Dis       Date:  2020-05-26       Impact factor: 4.123

10.  Tetrahydrobioterin (BH4) Pathway: From Metabolism to Neuropsychiatry.

Authors:  H Fanet; L Capuron; N Castanon; F Calon; S Vancassel
Journal:  Curr Neuropharmacol       Date:  2021       Impact factor: 7.363

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.